Brief: Arch Biopartners' GMP nanufacturing of AB569 progresses to final production stage
28/09/2017 13:32
Sept 28 (Reuters) - Arch Biopartners Inc ARCH.V :
* Arch Biopartners Inc - good manufacturing practice
production campaign for AB569 has advanced to GMP glass vial
filling stage
Source text for Eikon: ID:nMKWx4Sq1a
Further company coverage: ARCH.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Arch Biopartners
See all newsBrief: Arch Biopartners To Expand Phase Ii Cardiac Surgery-Associated Acute Kidney Injury Trial To The US
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Strengthens Its Position As A Leading Kidney Therapeutics Company With The Acquisition Of A Breakthrough Platform To Develop New Drugs Targeting Chronic Kidney Disease (Ckd)
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Biopartners Announces Ontario Research Ethics Board Approval To Start Phase II Trial For LSALT Peptide